Broesby-Olsen S et al. Omalizumab prevents anaphylaxis and improves symptoms
in systemic mastocytosis; efficacy and safety observations. Allergy 2017.
Recensione a cura di: Roberta Parente – Dipartimento di Medicina, Università degli Studi di Salerno
[VISUALIZZA PDF]
![](https://siaaic.org/wp-content/uploads/2023/03/siaaic_200x98.png)